- Home
- CCCC vs SRBK Comparison
CCCC vs SRBK Comparison
Compare CCCC & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- SRBK
- Stock Information
- Founded
- CCCC 2015
- SRBK 1887
- Country
- CCCC United States
- SRBK United States
- Employees
- CCCC N/A
- SRBK N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- SRBK
- Sector
- CCCC Health Care
- SRBK
- Exchange
- CCCC Nasdaq
- SRBK Nasdaq
- Market Cap
- CCCC 104.4M
- SRBK 117.4M
- IPO Year
- CCCC 2020
- SRBK N/A
- Fundamental
- Price
- CCCC $2.46
- SRBK $14.49
- Analyst Decision
- CCCC Buy
- SRBK
- Analyst Count
- CCCC 2
- SRBK 0
- Target Price
- CCCC $8.00
- SRBK N/A
- AVG Volume (30 Days)
- CCCC 1.5M
- SRBK 35.1K
- Earning Date
- CCCC 08-07-2025
- SRBK 07-31-2025
- Dividend Yield
- CCCC N/A
- SRBK 1.38%
- EPS Growth
- CCCC N/A
- SRBK N/A
- EPS
- CCCC N/A
- SRBK 0.44
- Revenue
- CCCC $34,240,000.00
- SRBK $31,833,000.00
- Revenue This Year
- CCCC N/A
- SRBK N/A
- Revenue Next Year
- CCCC N/A
- SRBK N/A
- P/E Ratio
- CCCC N/A
- SRBK $32.93
- Revenue Growth
- CCCC 16.55
- SRBK 39.53
- 52 Week Low
- CCCC $1.09
- SRBK $9.74
- 52 Week High
- CCCC $7.22
- SRBK $14.96
- Technical
- Relative Strength Index (RSI)
- CCCC 59.48
- SRBK 60.54
- Support Level
- CCCC $1.95
- SRBK $13.90
- Resistance Level
- CCCC $2.94
- SRBK $14.67
- Average True Range (ATR)
- CCCC 0.26
- SRBK 0.29
- MACD
- CCCC 0.00
- SRBK 0.01
- Stochastic Oscillator
- CCCC 51.52
- SRBK 83.93
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About SRBK SR Bancorp Inc. Common stock
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.